ProBio is a global contract development and manufacturing (CDMO) organization, which aims to accelerate the manufacturing of life-changing drugs, discover novel therapeutic targets, and develop innovative therapeutic approaches to manufacture best-in-class DNA, RNA, and protein-based therapeutics. As a global partner, ProBio brings together multi-disciplinary expertise to accelerate the manufacturing of advanced therapies, including biologics, protein and mRNA vaccines, viral vectors, antibody-drug conjugates and drug discovery services. We aid you in realizing the potential of your breakthrough discovery to treat diseases and improve lives. Let us accelerate your path to market with the greatest chance of success!
| Website | http://www.probiocdmo.com/ |
| Revenue | $58.5 million |
| Employees | 243 (148 on RocketReach) |
| Founded | 2020 |
| Address | 311 Pennington Rocky Hill Rd Building 9, Pennington, New Jersey 08534, US |
| Industry | Biotechnology Research |
| Keywords | Cdmo, Contract Development Manufacturing, Pharmaceutical Manufacturing, Drug Development, Biopharmaceutical Manufacturing, Biologics Manufacturing, Therapeutic Drug Development, Process Development, Drug Discovery, Innovative Therapeutics, Cgmp Manufacturing, Custom Manufacturing, Drug Product Manufacturing, Cell Line Development, Analytical Testing, Protein Production, Clinical Trial Manufacturing, Quality Control, Fill Finish |
| Competitors | Thermo Fisher Scientific, Novartis, AbbVie, Lonza, Catalent Pharma Solutions, WuXi AppTec, Sartorius, Biocon, Lilly India, Samsung Biologics +38 more (view full list) |
Looking for a particular GenScript ProBio employee's phone or email?
The GenScript ProBio annual revenue was $58.5 million in 2026.
Jin Yin is the CTO, Head of CGT Technology Center of GenScript ProBio.
148 people are employed at GenScript ProBio.
GenScript ProBio is based in Pennington, New Jersey.